Victory Capital Management Inc. bought a new position in TOCAGEN INC (NASDAQ:TOCA) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 69,600 shares of the company’s stock, valued at approximately $837,000. Victory Capital Management Inc. owned about 0.35% of TOCAGEN INC at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of TOCA. TD Asset Management Inc. bought a new position in TOCAGEN INC in the 2nd quarter worth about $158,000. Schwab Charles Investment Management Inc. bought a new position in TOCAGEN INC in the 2nd quarter worth about $165,000. Alps Advisors Inc. bought a new position in TOCAGEN INC in the 2nd quarter worth about $215,000. Finally, Bank of New York Mellon Corp bought a new position in TOCAGEN INC in the 2nd quarter worth about $281,000. Hedge funds and other institutional investors own 37.87% of the company’s stock.
Several research firms have commented on TOCA. Zacks Investment Research upgraded shares of TOCAGEN INC from a “sell” rating to a “hold” rating in a research report on Thursday. Stifel Nicolaus restated a “buy” rating and issued a $24.00 target price on shares of TOCAGEN INC in a research report on Tuesday, July 25th.
TRADEMARK VIOLATION WARNING: This report was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://ledgergazette.com/2017/09/17/victory-capital-management-inc-buys-shares-of-69600-tocagen-inc-toca.html.
TOCAGEN INC (NASDAQ:TOCA) opened at 12.64 on Friday. TOCAGEN INC has a 52-week low of $9.68 and a 52-week high of $17.95. The firm has a 50-day moving average of $12.27 and a 200 day moving average of $13.40. The company’s market cap is $250.39 million.
TOCAGEN INC (NASDAQ:TOCA) last announced its quarterly earnings results on Wednesday, August 9th. The company reported ($0.56) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.52) by ($0.04). The company had revenue of $0.01 million for the quarter, compared to analysts’ expectations of $0.01 million. Equities research analysts expect that TOCAGEN INC will post ($2.51) earnings per share for the current fiscal year.
TOCAGEN INC Profile
Tocagen Inc (Tocagen) is a clinical-stage, cancer-selective gene therapy company. The Company is focused on developing product candidates designed to activate a patient’s immune system against their own cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to selectively deliver therapeutic genes into the deoxyribonucleic acid (DNA) of cancer cells.
Want to see what other hedge funds are holding TOCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TOCAGEN INC (NASDAQ:TOCA).
Receive News & Ratings for TOCAGEN INC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TOCAGEN INC and related companies with MarketBeat.com's FREE daily email newsletter.